ESC Premium Access

Stroke and bleeding in low, intermediate and high risk patients with atrial fibrillation treated with edoxaban: Results of the ETNA-AF Europe registry

Congress Presentation

About the speaker

Professor Joris R De Groot

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
10 presentations
2 followers

9 more presentations in this session

Sex differences in admission rates, use of anticoagulation, and outcomes for emergency department presentations of atrial fibrillation

Speaker: Mr P. Daniele (Vancouver, CA)

Thumbnail

Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort study.

Speaker: Mr C. Binding (Gentofte, DK)

Thumbnail

Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study

Speaker: Assistant Professor H. Yu (Seoul, KR)

Thumbnail

Factors associated with inappropriate under-dosing of non-vitamin k antagonist oral anticoagulants (NOACs) by labelling criterion in patients with non-valvular atrial fibrillation in the UK

Speaker: Doctor A. Ruigomez (Madrid, ES)

Thumbnail

New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation

Speaker: Doctor T. Nakano (Hiroshima, JP)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 2

Speakers: Professor J. De Groot, Mr P. Daniele, Mr C. Binding, Assistant Professor H. Yu, Doctor A. Ruigomez...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk